We are live on ! Find out more
SBIO icon

ALPS Medical Breakthroughs ETF
SBIO

39 hedge funds and large institutions have $38.8M invested in ALPS Medical Breakthroughs ETF in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 16 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

272% more call options, than puts

Call options by funds: $201K | Put options by funds: $54K

0.56% more ownership

Funds ownership: 40.26% → 40.82% (+0.56%)

13% less capital invested

Capital invested by funds: $44.6M → $38.8M (-$5.87M)

19% less funds holding

Funds holding: 48 → 39 (-9)

63% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 16

69% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 13

Holders
39
Holders Change
-9
Holders Change %
-18.75%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
16
Closed
13
Calls
$201K
Puts
$54K
Net Calls
+$147K
Net Calls Change
-$38K

Top Buyers

Rank Fund Capital Flow
1
DC
Davenport & Co
Virginia
+$2.34M
2
SFS
Strategic Financial Services
New York
+$864K
3
RI
Ridgewood Investments
New Jersey
+$851K
4
Stifel Financial
Stifel Financial
Missouri
+$759K
5
Bank of America
Bank of America
North Carolina
+$631K

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1.35M
2
AC
ASB Consultores
Florida
-$783K
3
Citadel Advisors
Citadel Advisors
Florida
-$672K
4
Morgan Stanley
Morgan Stanley
New York
-$635K
5
Cetera Investment Advisers
Cetera Investment Advisers
Illinois
-$580K
Name Holding Trade Value Shares
Change 		Change in
Stake
HWM
26
HighMark Wealth Management
Minnesota
$20.4K +$6.04K +200 +36%
CT
27
Cambridge Trust
Massachusetts
$14K -$1.51K -50 -9%
CG
28
Cutler Group
California
$7K -$3.02K -100 -26%
S
29
SignatureFD
Georgia
$5.44K – – –
ADL
30
Asset Dedication LLC
California
$5K – – –
ASN
31
Advisory Services Network
Georgia
$4.08K – – –
VNA
32
Valley National Advisers
Pennsylvania
$4K – – –
FFA
33
Farther Finance Advisors
California
$3.48K – – –
IA
34
IFP Advisors
Florida
$3.22K -$132K -4,365 -98%
TRCT
35
Tower Research Capital (TRC)
New York
$3K – – –
FCB
36
First Command Bank
Texas
$2.72K – – –
FCFS
37
First Command Financial Services
Texas
$2.72K – – –
CCA
38
Column Capital Advisors
Indiana
$2.72K +$3.02K +100 New
AFG
39
Albion Financial Group
Utah
$327 – – –
AC
40
ASB Consultores
Florida
– -$783K -25,771 Closed
Cetera Investment Advisers
41
Cetera Investment Advisers
Illinois
– -$580K -19,081 Closed
Commonwealth Equity Services
42
Commonwealth Equity Services
Massachusetts
– -$527K -17,374 Closed
JIP
43
Jaffetilchin Investment Partners
Florida
– -$447K -14,711 Closed
SFG
44
Summit Financial Group
West Virginia
– -$264K -8,700 Closed
RJA
45
Raymond James & Associates
Florida
– -$229K -7,554 Closed
IAIM
46
International Assets Investment Management
Florida
– -$202K -5,425 Closed
William Blair & Company
47
William Blair & Company
Illinois
– -$102K -3,344 Closed
Carson Wealth (CWM LLC)
48
Carson Wealth (CWM LLC)
Nebraska
– -$55K -1,800 Closed
NA
49
NewEdge Advisors
Louisiana
– -$12.2K -400 Closed
First Manhattan
50
First Manhattan
New York
– -$9.11K -300 Closed
1
2
3

SBIO Hedge Fund Activity: Q1 2023 in Review

39 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q1 2023, worth a combined $38.8M — down 13% from $44.6M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of SBIO and 4 opened new positions — a net loss of 9 holders — while 16 trimmed existing stakes and 6 added.

The largest buyer was Davenport & Co, adding an estimated $2.34M. The largest seller was Royal Bank of Canada, cutting an estimated $1.35M.

  • 39 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q1 2023, down from 48 in Q4 2022.
  • Funds reported $38.8M of ALPS Medical Breakthroughs ETF stock for Q1 2023, down 13% quarter-over-quarter.
  • 4 funds opened new ALPS Medical Breakthroughs ETF positions in Q1 2023 and 13 closed out, a net change of -9 holders.
  • The largest ALPS Medical Breakthroughs ETF buyer in Q1 2023 was Davenport & Co, an estimated $2.34M added.
  • The largest ALPS Medical Breakthroughs ETF seller in Q1 2023 was Royal Bank of Canada, an estimated $1.35M sold.

Based on aggregated 13F filings for Q1 2023.